Literature DB >> 10467072

Significant pulmonary valve incompetence following oversize balloon pulmonary valveplasty in small infants: A long-term follow-up study.

W Berman1, R R Fripp, B D Raisher, S M Yabek.   

Abstract

Oversized dilatation balloons are recommended for relief of valvar pulmonic stenosis in infants and children during cardiac catheterization. Little information exists about the long-term outcome of this practice. Six of 107 consecutive patients undergoing balloon pulmonary valveplasty developed increasing pulmonary valve incompetence during follow-up periods of 0.5-10 years (mean, 7.2 years). Secondary right ventricular dilatation prompted insertion of a bioprosthetic pulmonary valve in one patient 6.8 years after intervention; valve replacement is pending in two additional patients, 4.3 and 10 years after intervention, respectively; and the three remaining subjects are thought likely to require valve replacement during childhood. The six reported subjects differ from the pulmonary valveplasty group as a whole in that they are younger (median age, 3 days vs. 11 months), had a higher degree of obstruction (right/left ventricular systolic pressure ratio prior to valveplasty 1.28 vs. 0.92), and underwent dilatation with relatively oversized balloons (balloon diameter to pulmonary valve annulus ratio 1.44 vs. 1.08). The balloon diameter to valve annulus ratio did not exceed 1.5 in any subject. Caution is advised in the use of oversized dilatation balloons in neonates or young infants with severe or critical pulmonic stenosis. Long-term consequences of substantial pulmonary valve incompetence outweigh, in our opinion, the limited gradient relief achieved with smaller balloons, sometimes requiring a second dilatation of the valve at an older age and larger size. Cathet. Cardiovasc. Intervent. 48:61-65, 1999. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  1999        PMID: 10467072     DOI: 10.1002/(sici)1522-726x(199909)48:1<61::aid-ccd11>3.0.co;2-e

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  8 in total

1.  Pulmonary Stenosis.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-12

Review 2.  Pulmonic Valve Disease: Review of Pathology and Current Treatment Options.

Authors:  Mouhammad Fathallah; Richard A Krasuski
Journal:  Curr Cardiol Rep       Date:  2017-09-16       Impact factor: 2.931

3.  Long-Term Outcomes of Balloon Valvuloplasty for Isolated Pulmonary Valve Stenosis.

Authors:  Rajiv Devanagondi; Dan Peck; Janaki Sagi; Janet Donohue; Sunkyung Yu; Sara K Pasquali; Aimee K Armstrong
Journal:  Pediatr Cardiol       Date:  2016-11-08       Impact factor: 1.655

4.  Restenosis after balloon valvuloplasty in a dog with pulmonary stenosis.

Authors:  Hiroshi Sunahara; Yoko Fujii; Keisuke Sugimoto; Takuma Aoki; Gou Sugahara; Kinji Shirota
Journal:  J Vet Med Sci       Date:  2014-09-23       Impact factor: 1.267

5.  Pulmonary valve regurgitation following balloon valvuloplasty for pulmonary valve stenosis: Single center experience.

Authors:  Asim Yousuf Al Balushi; Hamood Al Shuaili; Murtadha Al Khabori; Salim Al Maskri
Journal:  Ann Pediatr Cardiol       Date:  2013-07

6.  Interventional Treatment of Pulmonary Valve Stenosis: A Single Center Experience.

Authors:  Shpend Idrizi; Ivan Milev; Planinka Zafirovska; Goce Tosheski; Zan Zimbakov; Vilma Ampova-Sokolov; Tanja Angjuseva; Zan Mitrev
Journal:  Open Access Maced J Med Sci       Date:  2015-08-25

7.  Percutaneous balloon valvuloplasty with Inoue balloon catheter technique for pulmonary valve stenosis in adolescents and adults.

Authors:  Charan Lanjewar; Milind Phadke; Arvind Singh; Girish Sabnis; Mahesh Jare; Prafulla Kerkar
Journal:  Indian Heart J       Date:  2017-03-01

8.  The Comparison between the Echocardiographic Data to the Cardiac Catheterization Data on the Diagnosis, Treatment, and Follow-Up in Patients Diagnosed as Pulmonary Valve Stenosis.

Authors:  Do Hoon Kim; Su-Jin Park; Jo Won Jung; Nam Kyun Kim; Jae Young Choi
Journal:  J Cardiovasc Ultrasound       Date:  2013-03-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.